161 related articles for article (PubMed ID: 38478488)
1. Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial.
Campbell NG; Allen E; Evans R; Jamal Z; Opondo C; Sanders J; Sturgess J; Montgomery HE; Elbourne D; O'Brien B
PLoS One; 2024; 19(3):e0296525. PubMed ID: 38478488
[TBL] [Abstract][Full Text] [Related]
2. The impact of maintaining serum potassium ≥3.6 mEq/L vs ≥4.5 mEq/L on the incidence of new-onset atrial fibrillation in the first 120 hours after isolated elective coronary artery bypass grafting - study protocol for a randomised feasibility trial for the proposed Tight K randomized non-inferiority trial.
Campbell NG; Allen E; Sanders J; Swinson R; Birch S; Sturgess J; Al-Subaie N; Elbourne D; Montgomery H; O'Brien B
Trials; 2017 Dec; 18(1):618. PubMed ID: 29282098
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of Serum Potassium Levels ≥3.6 mEq/L Versus ≥4.5 mEq/L After Isolated Elective Coronary Artery Bypass Grafting and the Incidence of New-Onset Atrial Fibrillation: Pilot and Feasibility Study Results.
Campbell NG; Allen E; Montgomery H; Aron J; Canter RR; Dodd M; Sanders J; Sturgess J; Elbourne D; O'Brien B
J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):847-854. PubMed ID: 34404592
[TBL] [Abstract][Full Text] [Related]
4. Correction: Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial.
Campbell NG; Allen E; Evans R; Jamal Z; Opondo C; Sanders J; Sturgess J; Montgomery HE; Elbourne D; O'Brien B
PLoS One; 2024; 19(5):e0304230. PubMed ID: 38768402
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation incidence after coronary artery bypass graft surgery and percutaneous coronary intervention: the prospective AFAF cohort study.
Wickbom A; Fengsrud E; Alfredsson J; Engdahl J; Kalm T; Ahlsson A
Scand Cardiovasc J; 2024 Dec; 58(1):2347297. PubMed ID: 38695238
[No Abstract] [Full Text] [Related]
7. Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery.
Kaplan M; Kut MS; Icer UA; Demirtas MM
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):344-52. PubMed ID: 12579104
[TBL] [Abstract][Full Text] [Related]
8. Underestimation of the incidence of new-onset post-coronary artery bypass grafting atrial fibrillation and its impact on 30-day mortality.
Filardo G; Pollock BD; da Graca B; Phan TK; Sass DM; Ailawadi G; Thourani V; Damiano R
J Thorac Cardiovasc Surg; 2017 Oct; 154(4):1260-1266. PubMed ID: 28697894
[TBL] [Abstract][Full Text] [Related]
9. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
Kosmidou I; Chen S; Kappetein AP; Serruys PW; Gersh BJ; Puskas JD; Kandzari DE; Taggart DP; Morice MC; Buszman PE; Bochenek A; Schampaert E; Pagé P; Sabik JF; McAndrew T; Redfors B; Ben-Yehuda O; Stone GW
J Am Coll Cardiol; 2018 Feb; 71(7):739-748. PubMed ID: 29447735
[TBL] [Abstract][Full Text] [Related]
10. Posterior pericardiotomy to prevent new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis of 10 randomized controlled trials.
Xiong T; Pu L; Ma YF; Zhu YL; Li H; Cui X; Li YX
J Cardiothorac Surg; 2021 Aug; 16(1):233. PubMed ID: 34391454
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
Holm NR; Mäkikallio T; Lindsay MM; Spence MS; Erglis A; Menown IBA; Trovik T; Kellerth T; Kalinauskas G; Mogensen LJH; Nielsen PH; Niemelä M; Lassen JF; Oldroyd K; Berg G; Stradins P; Walsh SJ; Graham ANJ; Endresen PC; Fröbert O; Trivedi U; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
Lancet; 2020 Jan; 395(10219):191-199. PubMed ID: 31879028
[TBL] [Abstract][Full Text] [Related]
12. Prevention of atrial fibrillation and inflammatory response after on-pump coronary artery bypass using different statin dosages: a randomized, controlled trial.
Pierri MD; Crescenzi G; Zingaro C; D'Alfonso A; Capestro F; Scocco V; Brugia M; Torracca L
Gen Thorac Cardiovasc Surg; 2016 Jul; 64(7):395-402. PubMed ID: 27075863
[TBL] [Abstract][Full Text] [Related]
13. A double-blind randomized clinical trial comparing different doses of magnesium in cardioplegic solution for prevention of atrial fibrillation after coronary artery bypass graft surgery.
Gholipour Baradari A; Emami Zeydi A; Ghafari R; Aarabi M; Jafari M
Cardiovasc Ther; 2016 Aug; 34(4):276-82. PubMed ID: 27225338
[TBL] [Abstract][Full Text] [Related]
14. Glucosa-Insulin-Potassium (GIK) solution used with diabetic patients provides better recovery after coronary bypass operations.
Straus S; Gerc V; Kacila M; Faruk C
Med Arch; 2013; 67(2):84-7. PubMed ID: 24341049
[TBL] [Abstract][Full Text] [Related]
15. Changes in serum electrolyte levels and their influence on the incidence of atrial fibrillation after coronary artery bypass grafting surgery.
Svagzdiene M; Sirvinskas E
Medicina (Kaunas); 2006; 42(3):208-14. PubMed ID: 16607063
[TBL] [Abstract][Full Text] [Related]
16. Vernakalant: RSD 1235, RSD-1235, RSD1235.
Drugs R D; 2007; 8(4):259-65. PubMed ID: 17596113
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial.
Alexandre J; Ollitrault P; Fischer MO; Fellahi JL; Rozec B; Cholley B; Dolladille C; Chequel M; Allouche S; Legallois D; Saplacan V; Buklas D; Beygui F; Parienti JJ; Milliez P
Am Heart J; 2019 Aug; 214():88-96. PubMed ID: 31174055
[TBL] [Abstract][Full Text] [Related]
18. The effect of intravenous N-acetylcysteine on prevention of atrial fibrillation after coronary artery bypass graft surgery: a double-blind, randomised, placebo-controlled trial.
Soleimani A; Habibi MR; Hasanzadeh Kiabi F; Alipour A; Habibi V; Azizi S; Emami Zeydi A; Sohrabi FB
Kardiol Pol; 2018; 76(1):99-106. PubMed ID: 28980294
[TBL] [Abstract][Full Text] [Related]
19. New-Onset Perioperative Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Risk of Adverse Events: An Analysis From the CORONARY Trial.
Conen D; Wang MK; Devereaux PJ; Whitlock R; McIntyre WF; Healey JS; Yuan F; Yusuf S; Lamy A
J Am Heart Assoc; 2021 Jun; 10(12):e020426. PubMed ID: 34056913
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative plasma predictive factors of new-onset atrial fibrillation after coronary artery bypass graft surgery: A propensity score matching study].
Xu H; Zhang GD; Fan GP; Chen Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1139-1143. PubMed ID: 34916695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
